Agency / Source: Sartorius Stedim Biotech S.A.

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Sartorius Expands Production Site in England - New facility at the Stonehouse site for the manufacture of laboratory products | Officially opened by HRH Princess Anne, The Princess Royal - Sartorius-Stedim.com
Sartorius Expands Production Site in England

 

PRZOOM - /newswire/ - Goettingen, Germany, 2016/07/18 - New facility at the Stonehouse site for the manufacture of laboratory products | Officially opened by HRH Princess Anne, The Princess Royal - Sartorius-Stedim.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Sartorius, a leading international pharmaceutical and laboratory equipment provider, today opened a new plant at its Stonehouse site (Gloucestershire), doubling its local production capacities. Together with Princess Anne, member of the Royal Family, and nearly 100 guests, Group CEO Dr. Joachim Kreuzburg and Chris Biddell, the managing director of the U.K. subsidiary Sartorius Stedim Lab Ltd., officially opened the new building covering approximately 4,800 square meters (52,000 sq. ft.). Around 110 employees currently work at this facility in production and R&D.

In his opening speech, Joachim Kreuzburg stated: “Sartorius is growing dynamically, particularly with single-use products as are manufactured here in Stonehouse. To promote this positive development, we are currently investing substantially into the expansion of our global infrastructure. Since our acquisition of Vivascience back in 1999, this Stonehouse site continuously contributed to the strong development of the Sartorius Group. Our local team has achieved a very successful track record, so the new, larger plant is the next logical step.”

In Stonehouse, Sartorius (sartorius-stedim.com) develops and manufactures a variety of single-use plastic products, such as filtration units and laboratory-scale bioreactors. The approximately 9-million-euro new plant additionally serves as a competence center within the Sartorius Group for designing and manufacturing plastic components. Such products are used in laboratories and production facilities of pharmaceutical and biopharmaceutical companies and in research labs in academia. “The plant incorporates the latest technology and significantly expands our production capacity,” said Biddell. “At the same time, we have built it with an eye toward the future so that we will have sufficient space to once more double our production.”

Apart from the Stonehouse site, Sartorius also operates other sites within the United Kingdom in Royston, Epsom and Glasgow and employs nearly 500 people in total.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Sartorius Stedim Biotech S.A.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Sartorius Expands Production Site in England

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Sartorius Stedim Biotech |
Contact: Press Office - Sartorius-Stedim.com 
+33(0)4 42 84 56 00 press[.]sartorius-stedim.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Sartorius Stedim Biotech S.A. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Sartorius Stedim Biotech S.A. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Press Releases:

Ono Pharma Receives Orphan Medicinal Product Designation for Sapablursen from EC and Plans to Present Trial-in-Progress Poster At ASH 2026
Ono Pharma Announces Results from Five Phase 2 Clinical Studies of ONO-1110, an Endocannabinoid Modulator
NEC Contributes to AI Powered Vaccine Design through the EU Funded PREPAIR VAC Pandemic Preparedness Project
NEC Presents Phase I/II Results for Individualized Oral Neoantigen Therapy, NECVAX-NEO1 At ESMO 2026
Frost & Sullivan Awards WuXi AppTec with 2026 Global Company of the Year Recognition for CRDMO Leadership
Ono Pharma Announces an Exclusive License Agreement with Biohaven to Develop and Commercialize IgG Degraders in Japan, South Korea, Taiwan, and ASEAN
Ono Received Manufacturing and Marketing Approval in Japan for XCOPRI® Tablets for the Treatment of Patients with Partial-onset Seizures
Molecular Devices and STEMCELL Technologies Collaborate to Accelerate Adoption of Human-Relevant Organoid Models through Automation
ZAGENO Earns Frost & Sullivan’s 2026 North American Life Sciences E‑Commerce Company of the Year Recognition
SCHOTT Pharma, Takeda and Corplex Bring Closed-loop Recycling System for Pharmaceutical Vial Trays into Operations

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  RightITnow, Inc.

Visit BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona







 
  ©2005-2026 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS | 
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today